Analysis

In a year marked by significant revenue declines for major players in the mRNA and COVID-19 vaccine space, BioNTech SE...

Palantir Technologies is solidifying its long-term revenue streams through significant, simultaneous advancements in both its government and commercial sectors. The...

Investors have until Friday, April 3, to register as lead plaintiffs in a class action lawsuit against hydrogen fuel cell...

A new wave of price increases from Netflix has drawn sharp criticism from U.S. lawmakers, casting a shadow over the...

After a prolonged period of weakness across the software sector, investor interest in ServiceNow has returned. A combination of a...

In a stark demonstration of strategic realignment, Oracle unveiled two major developments this week that highlight its aggressive pivot towards...

Take-Two Interactive has closed its books on fiscal year 2026, with investor focus now squarely fixed on the horizon. The...

Biopharmaceutical firm Ocugen is transitioning from clinical development to the regulatory phase, with its lead gene therapy candidate approaching a...

In a rare admission, legendary investor Warren Buffett conceded to a significant error in judgment regarding his stake in Apple...

The independent Texas-based oil producer Battalion Oil is advancing a dual strategy to strengthen its financial foundation and sharpen its...